Skip to main content

Breast Cancer: Screening

Question for Department of Health and Social Care

UIN 118628, tabled on 4 February 2022

To ask the Secretary of State for Health and Social Care, what discussions he has had with the UK National Screening Committee on the potential merits of lowering the breast cancer screening age.

Answered on

10 February 2022

The UK National Screening Committee (UK NSC) awaits the publication of the Age Extension Trial before a recommendation can be made to the Department. The results of the AgeX trial will be critical to providing a better understanding of what the benefits and harms are for offering screening outside the recommended screening ages. Publication of the AgeX trial is expected in 2026.The UK NSC is in contact with the researchers and will be able to review the findings as soon as they are available. Any changes to national screening policy are made on the basis of robust evidence where the benefit to screen outweighs the harms.